Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,108 public trials 620 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation

NCT03483324

Conditions
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia, Bone Marrow Diseases, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of Colorado Cancer Center University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

NCT03128411

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Fujita Health University Hospital Toyoake, Aichi-ken, Japan
  • Toyohashi Municipal Hospital Toyohashi, Aichi-ken, Japan
  • Akita University Hospital Akita, Japan
  • Japanese Red Cross Narita Hospital Narita, Chiba, Japan
View all 21 locations
View Trial Details
Completed

Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

NCT02979366

Conditions
Acute Myeloid Leukaemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Patient Care Location: Smilow Cancer Hospital at Yale New Haven, Connecticut, United States
  • The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine Houston, Texas, United States
  • The Alfred Hospital Department of Haematology Melbourne, Australia
  • Royal Melbourne Hospital, Department of Clinical Haematology and BMT Service Melbourne, Australia
View Trial Details
Completed

A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)

NCT04509622

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • NHO Nagoya Medical Center /ID# 223671 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 223134 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 223133 Yoshida-gun, Fukui, Japan
  • Kyushu University Hospital /ID# 223136 Fukuoka, Japan
View all 16 locations
View Trial Details
Completed

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

NCT00450450

Conditions
Bone Marrow Diseases, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, +29 more
Locations
  • Children's Oncology Group Arcadia, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Childrens Memorial Hospital Chicago, Illinois, United States
View all 21 locations
View Trial Details

Related conditions